We treated BRAF mutant (A375 and SK-MEL-28) and BRAF wild type MEWO melanoma cells with specific inhibitors of JNK (SP600125), NF-κB (BAY11-7082) and p38 (SB203580 and SB202190). This evidence concerns the gene BRAF and melanoma.